Biomaterials for vaccine-based cancer immunotherapy
R Zhang, MM Billingsley, MJ Mitchell - Journal of Controlled Release, 2018 - Elsevier
The development of therapeutic cancer vaccines as a means to generate immune reactivity
against tumors has been explored since the early discovery of tumor-specific antigens by …
against tumors has been explored since the early discovery of tumor-specific antigens by …
Safety and efficacy of autologous tumor lysate particle-loaded dendritic cell vaccination in combination with systemic therapies in patients with recurrent and metastatic …
AM Adams, RC Chick, TJ Vreeland, GT Clifton… - Melanoma …, 2021 - journals.lww.com
Immunotherapy has revolutionized the treatment of melanoma, yet survival remains poor for
patients with metastatic disease. The autologous tumor lysate, particle-loaded, dendritic cell …
patients with metastatic disease. The autologous tumor lysate, particle-loaded, dendritic cell …